Cohere Health vs Develop Health
Two Prior Authorization vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Cohere Health | Develop Health | |
|---|---|---|
| Pricing model | Enterprise contract (custom) · scoped by UM volume and model | Free to providers (funded by payers/pharma) · pharma-funded, free for prescribers |
| Speed to go live | deep payer UM integration, multi-month program | API integration into existing EHR workflow |
| Automation model | Software platform · AI-assisted utilization management decisioning | Autonomous agents · automated benefit checks and PA submission |
| Built for | Payers | Small practices, Mid-size groups, Enterprise systems |
| Security posture | HITRUST, HIPAA | HIPAA |
| Company maturity | 7 yrs (est. 2019) | 4 yrs (est. 2022) |
| Financial backing | $200M · Series C | $17.6M · Series A |
| Named customers | 3 named | 4 named |
| Published results | Specific numbers public | No public numbers |
| Documented integrations | 3 listed | 2 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick Cohere Health if you are a health plan replacing legacy utilization management with AI-driven prior auth at Humana-proven scale.
- Pick Develop Health if medication prior auths bottleneck your prescribers and you want end-to-end PA automation at no cost to the practice.
Cohere Health
Intelligent prior auth platform for payers
- Founded
- 2019
- HQ
- Boston, MA
- Stage
- Series C
- Raised
- $200M
What it does
- Automates prior auth intake, review, and approval for health plans
- Auto-approves up to 90 percent of eligible auth requests
- Applies evidence-based clinical policies and physician-facing nudges
- Provider performance analytics to steer utilization management
- Payment integrity claims validation via Cohere Validate
- Delegated UM services across MSK, cardiology, imaging, sleep
Where it's strong
- Proven at national scale: over 12 million prior auth requests a year across roughly 600,000 providers, including a nationwide Humana deployment.
- High auto-approval rates (up to 90 percent) materially cut turnaround times and provider abrasion, which matters as CMS-0057 deadlines arrive.
- Well capitalized at $200M raised and expanding beyond prior auth into payment integrity, reducing single-product risk.
What buyers should weigh
- It sells to health plans, not providers; a provider organization only encounters Cohere through a payer that has adopted it.
- Much of its track record is concentrated in the Humana relationship, so plans of smaller size should ask for comparable references.
- Delegated UM and clinical policy alignment make implementations substantial projects with real compliance and integration work, not a light SaaS install.
Named customers
Humana · Geisinger Health Plan · Medical Mutual of Ohio
Integrations
Develop Health
AI benefit verification and prior auth for prescriptions
- Founded
- 2022
- HQ
- Menlo Park, CA
- Stage
- Series A
- Raised
- $17.6M
What it does
- Real-time benefit verification with plan-specific cost and coverage
- Predicts coverage and PA requirements at point of prescription
- Generates and submits prescription prior authorization packages
- Drafts appeals and manages denials automatically
- Returns structured coverage data into the prescriber's EHR
Where it's strong
- Purpose-built for prescription drug access (benefit checks plus medication PA), a narrower and deeper wedge than general prior auth vendors.
- Named traction with high-volume telehealth prescribers like Ro and LifeMD, where GLP-1 coverage friction makes the ROI easy to measure.
- Founders came from Canvas Medical and Rupa Health, so the product is built around real prescriber workflow integration rather than a standalone portal.
What buyers should weigh
- Total funding of $17.6 million and a 2022 founding date make this an early-stage vendor bet; assess team depth and support model before committing core volume.
- Public proof points are concentrated in telehealth and virtual care companies, so traditional health systems and pharmacies will find fewer reference customers.
- Scope is medications only; if you also need procedure, imaging, or DME prior auth, you will still need another vendor.
Named customers
Ro · LifeMD · Calibrate · Sunrise
Integrations
Compare against the rest of Prior Authorization
Deciding between these two?
First Pass tracks Prior Authorization every week: funding, launches, and what changed since this page was written.